Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
50242-0260-01 - HYALURONIDASE/PERTUZUMAB/TRASTUZUMAB 20,000 UNITS-600 MG-600 MG/10 ML SOL (OTHER 4876943) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/4876943/by-state?code_type=OTHER
“50242-0260-01 - HYALURONIDASE/PERTUZUMAB/TRASTUZUMAB 20,000 UNITS-600 MG-600 MG/10 ML SOL (OTHER 4876943) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4876943/by-state?code_type=OTHER. Accessed
June 30, 2026 .
“50242-0260-01 - HYALURONIDASE/PERTUZUMAB/TRASTUZUMAB 20,000 UNITS-600 MG-600 MG/10 ML SOL (OTHER 4876943) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/4876943/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
4876943 — 50242-0260-01 - Hyaluronidase/pertuzumab/trastuzumab 20,000 Units-600 Mg-600 Mg/10 Ml Sol
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$26,621
National median
$23,277 – $29,604
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4876943 (OTHER), with interquartile range
State Median p25 p75
CO $26,621 $23,277 $29,604